Analysis of prostate DCE-MRI: comparison of fast exchange limit and fast exchange regimen pharmacokinetic models in the discrimination of malignant from normal tissue.
about
Parallel MR imagingCurrent and future trends in magnetic resonance imaging assessments of the response of breast tumors to neoadjuvant chemotherapy.Cell membrane water exchange effects in prostate DCE-MRI.Normal central zone of the prostate and central zone involvement by prostate cancer: clinical and MR imaging implications.Statistical comparison of dynamic contrast-enhanced MRI pharmacokinetic models in human breast cancer.Models and methods for analyzing DCE-MRI: a review.Comparison of intravoxel incoherent motion diffusion-weighted MR imaging with dynamic contrast-enhanced MRI for differentiating lung cancer from benign solitary pulmonary lesions.Patient-specific pharmacokinetic parameter estimation on dynamic contrast-enhanced MRI of prostate: Preliminary evaluation of a novel AIF-free estimation method.Feasibility of shutter-speed DCE-MRI for improved prostate cancer detection.Feasibility of T2 -weighted turbo spin echo imaging of the human prostate at 7 tesla.Dynamic Contrast-Enhanced MRI-Derived Intracellular Water Lifetime (τ i ): A Prognostic Marker for Patients with Head and Neck Squamous Cell Carcinomas.Volume-normalized transfer constant as an imaging biomarker for chronic inflammatory arthritis: A dynamic contrast enhanced MRI study.Benign prostatic hyperplasia after prostatic arterial embolization in a canine model: A 3T multiparametric MRI and whole-mount step-section pathology correlated longitudinal study.Dynamic Contrast-enhanced Magnetic Resonance Imaging for Differentiating Between Primary Tumor, Metastatic Node and Normal Tissue in Head and Neck Cancer.
P2860
Q26862836-3C68A9C0-A8E1-402E-A02C-938597F80821Q34189855-6667C693-8F3D-4AC2-98FA-97243BFA1938Q34266549-9506EABF-0AF2-42B2-AE66-C6D9148B3199Q35773547-20E7F250-F9F2-4D48-AF65-C04DC33281FCQ35794860-01225490-0799-4B83-83FB-33147D72C87BQ38282639-C594BEB5-10C4-4FFA-9685-65E4CC446CCCQ38580754-0F2C9EAF-220A-4FD4-AC9E-543B5F006AD9Q38861117-FC25DC6E-04C6-4D64-8172-9E64DC6A0B66Q42434167-86C7CBCC-93CD-4E47-AC33-310A90988112Q45802979-339220DE-16AB-409E-BF33-710C1FD4259BQ47793448-6F8CFB3A-FAD6-464F-B883-404956A23180Q48201534-925C8539-7A94-4678-804C-53954AE2E442Q53516097-AB487A7E-6D60-43E1-B283-7944B3170D31Q55285574-842F7EB6-3D47-4DE1-AB3C-1D7E315DAE7A
P2860
Analysis of prostate DCE-MRI: comparison of fast exchange limit and fast exchange regimen pharmacokinetic models in the discrimination of malignant from normal tissue.
description
2009 nî lūn-bûn
@nan
2009 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Analysis of prostate DCE-MRI: ...... malignant from normal tissue.
@ast
Analysis of prostate DCE-MRI: ...... malignant from normal tissue.
@en
type
label
Analysis of prostate DCE-MRI: ...... malignant from normal tissue.
@ast
Analysis of prostate DCE-MRI: ...... malignant from normal tissue.
@en
prefLabel
Analysis of prostate DCE-MRI: ...... malignant from normal tissue.
@ast
Analysis of prostate DCE-MRI: ...... malignant from normal tissue.
@en
P2093
P1476
Analysis of prostate DCE-MRI: ...... malignant from normal tissue.
@en
P2093
Bashar Zelhof
Gary P Liney
Lindsay W Turnbull
Martin D Pickles
Martin Lowry
Peter Gibbs
P304
P356
10.1097/RLI.0B013E3181B4C1FE
P577
2009-09-01T00:00:00Z